Braintree Labs Hit With Antitrust Suit Over MiraLax
By Erin Marie Daly · March 13, 2007, 12:00 AM EDT
A New York drug cooperative has filed a proposed class action against Braintree Laboratories Inc., accusing the drug maker of conspiring to block rivals from marketing a generic version of its...
To view the full article, register now.